News

ZoomInfo Achieves Extraordinary Success in Latest G2 Rankings

ZoomInfo Achieves Extraordinary Success in Latest G2 Rankings

ZoomInfo's Outstanding Performance in G2’s Fall 2024 Reports

Vancouver, Wash. — ZoomInfo (NASDAQ: ZI), the go-to-market platform that helps businesses effectively find, acquire, and grow their customer base, has reached an impressive milestone by securing 139 No. 1 rankings in G2’s Fall 2024 Reports. This achievement showcases the company’s strong dedication to customer satisfaction and its notable presence in more than 1,000 categories.

This year, ZoomInfo has remarkably boosted its rankings by 37%, covering 15 distinct categories. This success solidifies ZoomInfo's place in the top 0.01% of over 130,000 vendors assessed, confirming its role as an industry leader.

Raising the Bar with Quality Data and Insights

ZoomInfo’s solid standing in these rankings underlines the essential importance of high-quality data and actionable insights in supporting effective go-to-market (GTM) strategies. Features such as AI-powered selling and real-time buying signals play a significant role in the impressive range of resources that ZoomInfo users leverage for remarkable sales and marketing outcomes.

Key Highlights from the G2 Reports

ZoomInfo has proudly secured the top spot on 30 different Grids in the G2 Reports, particularly shining as the leading solution in the Enterprise category for Buyer Intent Data. Other notable achievements include:

  • Eight No. 1 category rankings, outpacing core competitors by seven.
  • Leading four grids in categories such as Market Intelligence, Lead Mining, and Email Verification.
  • A perfect 100% user satisfaction rating in crucial categories like Sales Intelligence and Market Intelligence.
  • Maintaining the No. 1 position in Enterprise grids for Marketing Account Intelligence and Lead Intelligence for 15 consecutive quarters.
  • Dominating the Marketing Account Intelligence Grid for 16 of the last 18 quarters, dating back to Summer 2020.
  • Receiving over 8,000 5-star reviews on G2, including a significant number for both ZoomInfo Sales and Chorus by ZoomInfo.

Company Growth and User Satisfaction

In addition to its numerous accolades, ZoomInfo has also experienced growth in its visibility, with 361 appearances in the Index Reports—an increase of 8 from the previous quarter. The company appeared consistently on 107 total grids, leading to a total of 986 aggregated reports, marking a growth of 38 appearances compared to the last quarter.

The significant insights from G2’s Fall 2024 Reports are based on advanced algorithms that evaluate customer satisfaction and market presence, utilizing real-time reviews and data from diverse sources.

About ZoomInfo

ZoomInfo (NASDAQ: ZI) is acclaimed as the top go-to-market platform for organizations looking to efficiently find and nurture their customers. With a global reach of over 35,000 businesses, ZoomInfo delivers accurate and timely data, insightful analysis, and cutting-edge technology. This platform improves operational efficiency, optimizes technology use, and aligns marketing and sales efforts all in one integrated space. Moreover, ZoomInfo takes pride in its commitment to data privacy, ensuring compliance with GDPR and CCPA while also achieving notable security and privacy certifications.

To discover how ZoomInfo can help scale business revenue effectively, check out their official website.

Frequently Asked Questions

1. What is G2's Fall 2024 Reports?

G2's Fall 2024 Reports assess customer satisfaction and market presence across various software categories using user feedback and reviews.

2. How many No. 1 rankings did ZoomInfo receive?

ZoomInfo achieved an impressive total of 139 No. 1 rankings across various categories.

3. In which categories did ZoomInfo excel?

ZoomInfo stood out in categories such as AI-powered selling, Market Intelligence, and Email Verification.

4. How does ZoomInfo ensure data privacy?

ZoomInfo adheres strictly to GDPR and CCPA regulations, guaranteeing robust data security and privacy standards.

5. What products does ZoomInfo provide?

ZoomInfo offers a range of tools for sales and marketing, including solutions for data management, market intelligence, and lead generation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Abu Dhabi's Youth Orchestra: A Cultural Revolution

Updated Category News Views 75

A New Dawn for Abu Dhabi's Musical Future Abu Dhabi's making some noise, and I don't mean just any kind of noise. We're talking about a symphony of opportunity. The Department of Culture and Tourism – Abu Dhabi just dropped big news—setting up a dedicated institution for the Youth Orchestra Abu Dhabi. This ain't just a pat on the cultural back; it's a whole new ball...

Continue Reading
Endava Class Action: Investor Concerns Unveiled

Updated Category News Views 45

What's Happened with Endava? Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems. A...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 334

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 341

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 132

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
AppLovin Faces Securities Class Action Amid Share Plunge

Updated Category News Views 22

AppLovin's Fall from Grace AppLovin Corporation's recent tumble from investor darling to beleaguered party in a securities class action isn’t just a misstep; it’s a full-fledged nosedive into troubled waters that no trader worth their salt would want to ignore. The story kicks off with a pair of sharply disappointing turns that sent shivers down the spines of anyone...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 89

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
Boar's Head Introduces Authentic Italian Ricotta

Updated Category News Views 13

Boar's Head Brings Verona's Ricotta Stateside Imagine walking into your kitchen and finding a slice of authentic Italy sitting right there on your counter. That's what Boar's Head promises with its introduction of Italian Ricotta All Natural Cheese. It’s not just cheese; it’s a culinary passport straight from Verona, Italy, crafted using traditional techniques that...

Continue Reading
Utopia Bagels Honored at 2026 New York BagelFest

Updated Category News Views 106

From Queens Streets to Global Fame Try to picture this: a small neighborhood shop where the scent of freshly baked bagels wafts through, bringing together old friends and new generations. Now, take that local magic and multiply it by a global stage. That's the journey Utopia Bagels from Queens stepped into with massive strides over 45 years, earning a celebrated spot in...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 104

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading

Top 5 Most Recently Viewed Articles

Demi Lovato Inspires Sustainability Through Gaming Initiative

Updated Category News Views 259

Demi Lovato Joins PlanetPlay for Sustainable Gaming Initiative Global superstar Demi Lovato has teamed up with PlanetPlay to launch an innovative initiative called 'Make Green Tuesday Moves' (MGTM). This campaign merges the dynamic realms of music, video games, and environmental awareness to engage fans and inspire them to take part in sustainable practices. Engaging Fans...

Continue Reading
Investigation into Grocery Outlet Performance by Faruqi & Faruqi

Updated Category News Views 113

Investigation into Grocery Outlet's Stock Performance Grocery Outlet Holding Corp. (NASDAQ: GO) finds itself under scrutiny amidst claims regarding its handling of recent transitions and system upgrades. Following substantial losses reported by investors, the law firm Faruqi & Faruqi, LLP has taken the initiative to assist those affected. Led by securities litigation...

Continue Reading
Les M. Ottolenghi Takes the Helm at VIP Play Inc.

Updated Category News Views 219

Les M. Ottolenghi Appointed CEO of VIP Play Inc. VIP Play Inc. (OTC: VIPZ), a Nevada-based online casino and gaming company, has proudly announced the appointment of Les M. Ottolenghi as the new Chief Executive Officer. With over twenty-five years of distinguished experience in the gaming and entertainment sectors, Ottolenghi is well-equipped to steer the company towards...

Continue Reading
Maximize Your Home Sale: Expert Tips from Findlay, OH

Updated Category News Views 7

First Impressions Set the Sale's Tone When it comes to selling your home, the first impression is everything. In Findlay, OH, local real estate expert Doug Finney and the fine folks at HelloNation outline that a good eyeball test can often make or break a sale. Pulling up to an immaculately maintained façade, buyers start dreaming rather than dreading. But if the lawn...

Continue Reading
Philips Announces Share Repurchase to Support Long-Term Goals

Updated Category News Views 175

Philips' Strategic Move to Repurchase Shares Royal Philips, a global leader in health technology, has taken an important step to reinforce its long-term incentive plans. The company has announced its intention to buy back up to 6 million shares, a move anticipated to reach around EUR 125 million at current market prices. This share repurchase reflects Philips' commitment...

Continue Reading